Biogenic synthesis of AgNPs using Artemisia oliveriana extract and their biological activities for an effective treatment of lung cancer
Source abstract
Abstract
Silver nanoparticles (AgNPs) were synthesized using Artemisia oliveriana extract, and their physicochemical characteristics were studied. The antioxidant and antimicrobial activities of the AgNPs, as well as their anticancer effects on the lung cancer cell line (A549), using 1,1-diphenyl-2-picrylhydrazyl (DPPH), MIC and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) techniques respectively demonstrated that the synthesized AgNPs mainly affected the gram-positive bacteria rather than the gram-negative bacteria, and exhibited significant cellular toxicity on the A549 cell line. Further, the cellular uptake of the AgNPs results indicated that the AgNPs accumulated within the cell. Moreover, their impact on the expression of apoptotic genes including Bax, Bcl-2, caspase-3 (CASP3), caspase-9 (CASP9) and miR-192 using real-time PCR demonstrated substantial increase in the expression of all mentioned genes (p<.001). Finally, the apoptotic effects of the AgNPs through DNA fragmentation test, flow cytometry and cell cycle analysis indicated the induction of apoptosis in the A549 cell line. The results revealed that the AgNPs synthesized using A. oliveriana extract have potential biological applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Young Researcher and Elite Club, East Tehran Branch, Islamic Azad University
Department of Biology, East Tehran Branch, Islamic Azad University
Department of Biotechnology, School of Advanced Technologies in Medicine
, Shahid Beheshti University of Medical Sciences
Department of Biology, Roudehen Branch, Islamic Azad University
Department of Microbiology, Parasitology, and Immunology, Guilan University of Medical Sciences
Department of Biology, Islamic Azad University of Tonekabon Branch
Funding
Nafiseh Nafisi Fard
References (39)
Show source-provided references
1. 10.1186/bcr198810.1186/bcr1988 ↗
2. 10.2174/13816121078994184710.2174/138161210789941847 ↗
3. 10.1053/j.seminoncol.2005.02.01610.1053/j.seminoncol.2005.02.016 ↗
4. 10.1177/135245851456448910.1177/1352458514564489 ↗
5. 10.1378/chest.123.1_suppl.21S10.1378/chest.123.1_suppl.21S ↗
6. 10.1158/1078-0432.CCR-07-487910.1158/1078-0432.CCR-07-4879 ↗
7. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res. 1989;49:4682–4689.
8. Collins LG, Haines C, Perkel R, et al. Lung cancer: diagnosis and management. Am Fam Phys. 2007;75:56–63.
9. 10.1016/j.ccr.2012.06.00810.1016/j.ccr.2012.06.008 ↗
10. 10.2174/15748921280182009310.2174/157489212801820093 ↗
11. 10.1146/annurev-pharmtox-010715-10345610.1146/annurev-pharmtox-010715-103456 ↗
12. 10.1016/j.addr.2012.09.03310.1016/j.addr.2012.09.033 ↗
13. 10.2174/13892001079111082710.2174/138920010791110827 ↗
14. 10.1016/j.biomaterials.2011.08.08510.1016/j.biomaterials.2011.08.085 ↗
15. 10.1021/bm500300910.1021/bm5003009 ↗
16. 10.1016/j.shaw.2013.07.00610.1016/j.shaw.2013.07.006 ↗
17. 10.3390/ijms1710160310.3390/ijms17101603 ↗
18. 10.1016/j.tiv.2016.10.01210.1016/j.tiv.2016.10.012 ↗
19. 10.1007/s00253-016-7657-710.1007/s00253-016-7657-7 ↗
20. 10.1007/s10661-017-6033-010.1007/s10661-017-6033-0 ↗
21. 10.1016/j.saa.2014.09.11810.1016/j.saa.2014.09.118 ↗
22. 10.1016/j.saa.2012.11.02810.1016/j.saa.2012.11.028 ↗
23. 10.1007/s12010-014-0831-410.1007/s12010-014-0831-4 ↗
24. 10.1016/j.ecoenv.2016.03.02110.1016/j.ecoenv.2016.03.021 ↗
25. 10.2147/IJN.S9988210.2147/IJN.S99882 ↗
26. 10.1002/jmr.256510.1002/jmr.2565 ↗
27. 10.1016/j.msec.2016.06.06610.1016/j.msec.2016.06.066 ↗
28. 10.1080/21691401.2016.122866310.1080/21691401.2016.1228663 ↗
29. 10.1080/22311866.2013.78275510.1080/22311866.2013.782755 ↗
30. 10.1093/nar/gkr23210.1093/nar/gkr232 ↗
31. 10.1016/j.cbi.2017.06.01910.1016/j.cbi.2017.06.019 ↗
32. 10.1080/17435390.2016.121476410.1080/17435390.2016.1214764 ↗
33. 10.2147/IJN.S12195610.2147/IJN.S121956 ↗
34. 10.1016/j.jfda.2014.01.01010.1016/j.jfda.2014.01.010 ↗
35. 10.1007/978-94-007-2869-1_1310.1007/978-94-007-2869-1_13 ↗
36. 10.1186/s12935-015-0204-210.1186/s12935-015-0204-2 ↗
37. 10.18632/oncotarget.352310.18632/oncotarget.3523 ↗
38. 10.1155/2014/31803010.1155/2014/318030 ↗
39. 10.1007/s13205-018-1199-x10.1007/s13205-018-1199-x ↗